Emerging studies suggest Retatru tide , a dual activator targeting both the gut-brain axis and another hormone, may provide a significant advancement for body loss . Preliminary clinical tests have shown substantial reductions in body tissue, conceivably outperforming current weight-loss therapies . Nevertheless , additional evaluation is needed to